Intra-cellular therapies, inc. (ITCI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
Assets
Current assets:
Cash and cash equivalents

179,593

107,636

102,162

91,763

64,091

54,947

69,776

69,767

74,421

37,790

52,340

29,590

23,598

48,642

200,388

51,972

37,240

47,159

332,828

71,418

100,802

61,325

68,915

91,140

143,618

35,150

44,072

-

-

15,645

Investment securities, available-for-sale

269,361

116,373

153,270

193,536

248,731

292,583

306,211

333,997

362,584

426,540

275,781

313,037

344,183

335,458

337,405

390,717

418,827

428,041

177,903

132,570

134,424

68,320

67,066

49,355

-

2,000

-

-

-

-

Restricted cash

1,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

-

2,000

-

-

3,500

Accounts receivable, net

1,351

-

-

-

-

-

-

-

-

-

6

61

68

94

1

98

0

30

-

9

3

51

124

219

167

336

251

-

-

300

Inventory

1,391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

7,876

6,313

4,023

3,041

8,305

7,908

7,265

5,896

6,148

4,884

5,307

6,144

3,761

4,005

4,023

4,020

6,790

8,025

1,532

8,612

1,267

1,288

1,374

493

585

762

806

-

-

188

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4

-

Total current assets

460,972

230,323

259,456

288,341

321,127

355,438

383,253

409,661

443,153

469,215

333,435

348,834

371,610

388,200

541,818

446,808

462,858

483,256

512,264

212,610

236,497

130,986

137,480

141,208

146,371

38,249

47,129

0

4

19,634

Property and equipment, net

2,132

2,259

2,174

2,082

1,125

1,159

1,196

1,275

1,349

1,137

679

628

605

627

677

718

731

775

785

722

559

54

57

63

65

68

75

-

-

58

Right of use assets, net

18,100

18,252

18,540

18,822

20,104

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset, net

-

264

264

529

529

529

1,058

1,058

1,058

1,058

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

86

86

86

86

86

78

78

78

77

75

75

75

75

75

75

75

71

71

71

70

70

70

70

70

200

131

130

-

-

130

Total assets

481,242

251,186

280,523

309,862

342,972

357,206

385,587

412,073

445,639

471,486

334,190

349,539

372,292

388,903

542,571

447,602

463,661

484,103

513,122

213,404

237,127

131,111

137,609

141,342

146,636

38,449

47,336

0

4

19,823

Liabilities and stockholders' equity
Current liabilities:
Borrowing under secured line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

125,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

10,994

7,425

6,230

5,632

8,574

13,961

10,453

5,378

10,038

6,173

4,407

1,775

7,157

3,754

5,417

3,889

1,959

1,632

705

4,911

4,574

2,052

503

415

2,142

3,395

4,027

-

-

41

Accrued and other current liabilities

10,667

16,138

17,323

18,801

18,700

20,044

14,168

10,462

7,355

6,424

4,151

2,781

7,039

5,329

7,520

12,981

5,241

3,423

8,575

3,340

9,029

7,529

2,143

1,434

940

2,611

2,571

-

-

404

Lease liabilities, short-term

3,211

3,187

2,286

2,262

2,873

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued employee benefits

6,203

9,472

7,531

5,829

3,351

2,293

4,507

3,094

2,257

1,611

3,316

2,406

2,121

1,448

2,752

2,509

1,745

1,207

1,106

1,066

988

975

929

888

828

827

759

-

-

726

Deferred revenue-short-term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

416

-

-

1,666

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

26

-

Loan payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

-

Note payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

0

-

Total current liabilities

31,076

36,224

33,373

32,526

33,499

36,299

29,128

18,935

19,652

14,209

11,875

6,962

16,318

10,532

140,689

19,381

8,946

6,263

10,386

9,318

14,592

10,557

3,577

2,739

3,911

6,834

7,774

33

26

2,839

Deferred rent

-

-

-

0

-

3,192

2,832

2,750

2,797

2,840

-

-

-

2,868

-

-

-

1,597

881

520

-

-

-

-

-

-

-

-

-

-

Lease liabilities

19,718

19,955

20,269

20,567

20,859

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

-

-

-

-

-

-

-

-

-

-

2,875

2,911

2,946

-

2,563

2,258

1,970

-

-

-

160

-

-

-

-

-

-

-

-

-

Total liabilities

50,794

56,179

53,642

53,094

54,358

39,491

31,961

21,686

22,450

17,049

14,750

9,873

19,265

13,400

143,253

21,640

10,917

7,860

11,268

9,838

14,752

10,557

-

-

-

-

-

-

-

-

Stockholders' equity:
COMMITMENTS AND CONTINGENCIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Preferred stock, $.0001 par value; 10,000,000 shares authorized; none issued and outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Common stock, $0.0001 par value: 100,000,000 shares authorized; 66,200,761 and 55,507,497 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

6

5

5

5

5

5

5

5

5

5

4

4

4

4

4

4

4

4

4

3

3

2

2

2

2

2

2

0

0

1

Additional paid-in capital

1,188,095

904,971

896,191

891,183

885,888

880,753

876,094

871,516

867,152

862,479

696,695

694,146

689,723

685,290

681,475

677,623

673,679

669,878

666,083

335,668

332,948

208,912

207,152

205,289

204,829

89,177

89,082

9

9

47,678

Accumulated deficit

-757,508

-710,098

-669,515

-634,653

-597,211

-562,376

-521,628

-480,105

-442,728

-407,248

-377,040

-354,169

-336,408

-309,475

-281,990

-251,725

-220,890

-193,049

-164,214

-132,054

-110,542

-88,255

-73,056

-66,641

-62,107

-57,564

-49,523

-

-

-30,696

Accumulated comprehensive (loss) gain

-145

128

199

232

-67

-667

-846

-1,029

-1,239

-799

-219

-315

-291

-317

-171

59

-49

-590

-19

-52

-33

-104

-67

-47

-

-

-

-

-

-

Accumulated deficit during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42

32

-

Total stockholders' equity

430,448

195,007

226,880

256,768

288,614

317,714

353,625

390,387

423,188

454,436

319,440

339,665

353,027

375,502

399,318

425,962

452,744

476,242

501,854

203,565

222,374

120,554

134,031

138,603

142,725

31,615

39,561

-32

-22

16,984

Total liabilities and stockholders' equity

481,242

251,186

280,523

309,862

342,972

357,206

385,587

412,073

445,639

471,486

334,190

349,539

372,292

388,903

542,571

447,602

463,661

484,103

513,122

213,404

237,127

131,111

137,609

141,342

146,636

38,449

47,336

0

4

19,823